{{Rsnum
|rsid=2396753
|Gene=FOXP2
|Chromosome=7
|position=114508276
|Orientation=plus
|GMAF=0.371
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=FOXP2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 30.6 | 48.4 | 21.0
| HCB | 32.6 | 53.5 | 14.0
| JPT | 17.8 | 53.3 | 28.9
| YRI | 67.8 | 30.5 | 1.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 32.6 | 53.5 | 14.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID|21334420}} rs2396753 (C>A) gene variant of the FOXP2 gene has significant effects on  grey matter concentration in patients with schizophrenia.

{{PMID Auto
|PMID=16538183
|Title=Association between FOXP2 polymorphisms and schizophrenia with auditory hallucinations.
}}

{{PMID Auto
|PMID=20649982
|Title=FOXP2 gene and language impairment in schizophrenia: association and epigenetic studies.
|OA=1
}}

{{PMID Auto
|PMID=20858950
|Title=The speech and language FOXP2 gene modulates the phenotype of frontotemporal lobar degeneration.
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}